Transcatheter versus surgical aortic valve replacement in low-risk surgical patients: a meta-analysis of randomized clinical trials

B Kheiri, M Osman, H Abubakar, A Subahi… - Cardiovascular …, 2019 - Elsevier
Background Transcatheter aortic valve replacement (TAVR) is a valid option for patients with
high or intermediate surgical risk. However, clinical outcomes of TAVR in low-risk patients …

Transcatheter aortic valve replacement versus surgical aortic valve replacement in low‐surgical‐risk patients: an updated meta‐analysis

S Goel, RT Pasam, K Wats, J Patel… - Catheterization and …, 2020 - Wiley Online Library
Objective The purpose of this meta‐analysis is to compare the safety and efficacy of
transcatheter aortic‐valve replacement (TAVR) to surgical aortic valve replacement (SAVR) …

Transcatheter versus surgical aortic valve replacement in patients with lower surgical risk scores: a systematic review and meta-analysis of early outcomes

S Arora, PD Strassle, CJ Ramm, JA Rhodes… - Heart, Lung and …, 2017 - Elsevier
Background The results from the PARTNER 2 trial showed the feasibility of transcatheter
aortic valve replacement (TAVR) in intermediate surgical risk patients. Although low risk …

Transcatheter versus surgical aortic valve replacement in patients at low surgical risk: a meta‐analysis of randomized trials and propensity score matched …

G Witberg, A Lador, D Yahav… - Catheterization and …, 2018 - Wiley Online Library
Background Although transcatheter aortic valve replacement (TAVR) is officially indicated for
high risk aortic stenosis (AS) patients, the procedure is increasingly being performed in …

Transcatheter versus surgical aortic valve replacement in low-risk patients: a meta-analysis of randomized trials

F Hofer, C Hengstenberg, G Goliasch, M Grygier… - Clinical Research in …, 2020 - Springer
Background Transcatheter aortic valve replacement (TAVR) has emerged as a treatment
option for severe aortic stenosis in patients at intermediate or high surgical risk. However …

Transcatheter versus surgical aortic valve replacement in moderate and high-risk patients: a meta-analysis

M Carnero-Alcázar, LC Maroto… - European Journal of …, 2017 - academic.oup.com
OBJECTIVES: The evidence of the benefits of transcatheter aortic valve replacement (TAVR)
or surgical aortic valve replacement (SAVR) for patients of high or intermediate surgical risk …

[HTML][HTML] Transcatheter versus surgical aortic valve replacement in intermediate risk patients: a meta-analysis

S Arora, JA Misenheimer, W Jones… - Cardiovascular …, 2016 - ncbi.nlm.nih.gov
Background Transcatheter aortic valve replacement (TAVR) has been approved in patients
with high or prohibited surgical risk for surgery for treatment of severe symptomatic aortic …

Transcatheter aortic valve replacement in low-risk patients: a meta-analysis of randomized controlled trials

A Al-Abdouh, S Upadhrasta, O Fashanu, H Elias… - Cardiovascular …, 2020 - Elsevier
Introduction Transcatheter aortic valve replacement (TAVR) has become the standard
treatment option for patients with symptomatic severe aortic stenosis (AS) with high surgical …

Low-risk transcatheter versus surgical aortic valve replacement–an updated meta-analysis of randomized controlled trials

M Anantha-Narayanan, VV Kandasamy… - Cardiovascular …, 2020 - Elsevier
Objectives To perform a meta-analysis including all available randomized controlled trials
(RCTs) to date comparing transcatheter aortic valve replacement (TAVR) to surgical aortic …

Transcatheter versus surgical aortic valve replacement in low to intermediate risk patients: A meta-analysis of randomized and observational studies

Y Zhou, Y Wang, Y Wu, J Zhu - International Journal of Cardiology, 2017 - Elsevier
Background Transcatheter aortic valve replacement (TAVR) has become the treatment of
choice for patients with aortic stenosis and the preferred alternative for high surgical risk …